February 10th, 2020
•Blood-based biomarkers for neurodegenerative diseases are essential for implementing large-scale clinical studies. A reliable and validated blood test should require a small sample volume as well as be a less invasive sampling method, affordable, and reproducible. This paper demonstrates that high-throughput capillary electrophoresis immunoassay satisfies criteria for potential biomarker development.
Tags
Vídeos Relacionados
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Exploring Deep Space - Uncovering the Anatomy of Periventricular Structures to Reveal the Lateral Ventricles of the Human Brain
In Vivo Calcium Imaging of Lateral-line Hair Cells in Larval Zebrafish
Use of In Vivo Single-fiber Recording and Intact Dorsal Root Ganglion with Attached Sciatic Nerve to Examine the Mechanism of Conduction Failure
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Activity of Posterior Lateral Line Afferent Neurons during Swimming in Zebrafish
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados